|
|
|
CC Forecast
Recent CC Price |
|
CC Forecast Price |
$28.88 |
-3.05% |
$28.00 |
As of 2024-03-28
Recent CC Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
0 |
2 |
2 |
2 |
Buy ratings: |
1 |
1 |
1 |
1 |
Hold ratings: |
6 |
5 |
5 |
5 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
1 |
0 |
0 |
0 |
Average rating: |
3.13 |
2.38 |
2.38 |
2.38 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the Chemours Co (The) forecast (traded under symbol CC) for one year forward price target at the top of this page, we have presented the average CC forecast for forward target price across the 8 analysts covering CC, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median CC forecast price target (median being the middle where half of analysts had a higher CC forecast and half had a lower CC forecast, which is a different metric than the average or mean) was $28.0 as of 2024-03-28, while the
highest CC forecast in the analyst group was $40.0, and the lowest CC forecast in the analyst group was
$19.0, with a standard deviation of $6.611. Get the latest Zacks research report on CC — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
Chemours Co (The) |
Website: |
www.chemours.com |
Sector: |
Specialty Chemicals |
Number of ETFs Holding CC: |
55 (see which ones) |
Total Market Value Held by ETFs: |
$721,922,205.96 |
Total Market Capitalization: |
$4,063,000,000 |
% of Market Cap. Held by ETFs: |
17.77% |
|
|
|
|
Hold (1.87 out of 4)
0th percentile
|
PARTNER NEWS:Wed, Mar 27, 5:00 PM, Zacks
Chemours (CC) Q4 Earnings Top Estimates Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.69%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Fri, Jan 26, 9:10 AM, Zacks
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
|
|